Fibro Calc

FibroCalc

FibroCalc and Acticalc estimate both fibrosis and necroinflammatory activity with a blood sample done at a local laboratory. Same highly significant performance for both advanced fibrosis and cirrhosis regardless of ethnicity, HBeAg status, HCV genotype, viral load, gender or ALT transaminase level.

ActiCalc is more accurate than ALT transaminases for the diagnosis of necroinflammatory activity.
FibroCalc is as performant in the diagnosis of early stages of fibrosis as it is in more advanced stages , from no fibrosis to cirrhosis.

best applicability among all non-invasive methods (98%).

Order Demo

ASh Test

There is another option for fatty liver determination If you add Fasting Glucose, Cholestrol, Tryglycerids, AST and BMI to FIBROCALC values then it is possible to determine Fatty Liver and ASh parameters.. The biochemistry parameters are as follows:

Haptoglubin
alpha2 macroglubulin
Apolipoprotein A1
Apolipoprotein B
Total Billirubin
Fasting Glucose
Cholestrol
Tryglycerids
AST
ALT
GGT
BMI

Fibrocalc – ActiCalc

An innovative noninvasive method for Liver fibrosis and cirrhosis level detection specially for HBV,HCV and HIV patients which suffering from Liver problems. The results are comparable with fibroscan and can decrease Biopsy operation of liver. These method uses 7 biochemistry parameters of body plus age and gender. The biochemistry parameters are as follows:

Haptoglubin
alpha2 macroglubulin
Apolipoprotein A1
Apolipoprotein B
Total Billirubin
ALT
GGT

Discussions

Fibrocalc can be used in parallel with Fibroscan to decrease biopsy operation.
Fibrocalc is low risk and low cost system which can be used for patients monitoring and screening in a society.
Fibrocalc software is easy to use with flexible report format and a powerful data management system to trace patients and can send reports to everywhere In the world automatically by Laboratory decisions.
Fibrocalc is high secure software which keep patients information private.

Fibrocalc advantages vs Fibroscan and Biopsy

Good for screening specially for Fatty Liver disease
Less operational faults
Noninvasive method
Acceptable results
Lower price
No pain

Follow-up

FibroCalc and ActiCalc are easily repeatable for the assessment of disease progression.
Unlike the elastographic methods, repeated FibroCalc in HBV patients do not have variability related to necroinflammatory activity.
Performance of FibroCalc and ActiCalc was similar to biopsy for assessing fibrosis and activity regression in HCV treatment.